Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-08-05

FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (Biocon Pharma Inc.)

View source ↗

Summary

FDA approved Biocon Pharma Inc.'s supplemental application for pravastatin sodium, authorizing continued marketing of the product as a statin-indicated therapy …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pravastatin Sodium (pravastatin sodium)

Snippet

SUPPL AP for PRAVASTATIN SODIUM (PRAVASTATIN SODIUM)